Clinical Report: Glaucoma in the UK
Overview
Glaucoma UK has initiated the largest patient insight survey in the UK, running from 6 July to 6 September 2026, to gather experiences from individuals living with glaucoma. The survey aims to inform future glaucoma services and address unmet needs in patient care.
Background
Glaucoma is the second leading cause of irreversible sight loss in the UK, affecting over one million people, with projections indicating a significant increase in cases by 2060, according to research from Moorfields Eye Hospital and University College London. The condition often goes undiagnosed, highlighting the need for improved patient engagement and understanding of their experiences. This survey represents a critical effort to capture patient perspectives and inform healthcare service development.
Data Highlights
No numerical data available in the provided source material.
Key Findings
- The National Patient Voices Survey aims to gather insights from around 10,000 glaucoma patients in the UK.
- Research estimates that over one million adults aged 40 and over in the UK are living with glaucoma, with many undiagnosed.
- The number of glaucoma cases is projected to rise by 60% by 2060, reaching approximately 1.61 million, according to a population-based modeling study.
- The survey has been endorsed by key organizations including the Royal College of Ophthalmologists and The College of Optometrists.
- Healthcare professionals are encouraged to support the survey to ensure diverse patient voices are heard.
Clinical Implications
The insights gained from this survey may help shape future glaucoma services and improve patient care. Engaging with patients' experiences is essential for identifying unmet needs and enhancing treatment pathways.
Conclusion
The launch of this extensive survey is aimed at understanding the patient experience in glaucoma care, which is essential for future service development.
Related Resources & Content
- Glaucoma UK, Glaucoma UK, 2023 -- Glaucoma in the UK
- the ophthalmologist, Rethinking UK Glaucoma Care, 2026 -- Rethinking UK Glaucoma Care
- the ophthalmologist, UK: More than a Million Over 40s Living with Glaucoma, 2026 -- UK: More than a Million Over 40s Living with Glaucoma
- the ophthalmologist, New UK Framework for Glaucoma Care, 2026 -- New UK Framework for Glaucoma Care
- Glaucoma Physician — Glaucoma in Africa
- NICE Guidelines for Glaucoma
- European Glaucoma Society Guidelines
- American Academy of Ophthalmology Preferred Practice Pattern
- Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study - ScienceDirect
- Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY Study | Ophthalmology and Therapy | Springer Nature Link
- Ocular Hypertension Treatment Study: Effect of time after incident glaucoma on OCT optic nerve head and macula measurements - ScienceDirect
- What is the long-term efficacy and safety of selective laser trabeculoplasty in the management of primary open-angle glaucoma? A systematic review and meta-analysis - ScienceDirect
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.